New Technology

New Technology

Should artificial intelligence be used in conjunction with Neuroimaging in the diagnosis of Alzheimer’s disease?

Dementia, or Major Neurocognitive Disorder (MND), is a general term for any disease that causes a substantial decline in at least one cognitive domain including memory, learning, executive function, and additionally, impairs an individual’s ability to perform daily tasks. Alzheimer’s disease (AD) can be divided into three stages: early-stage (mild), middle-stage (moderate), and late-stage (severe). Each phase serves to classify the development of

Read More »
New Technology

Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer’s disease using EEG technology

Alzheimer’s disease (AD) is the leading cause of dementia, accounting for an estimated 60-80% of cases worldwide. Presently, there is no effective treatment for AD and only very limited medicines show the potential for delaying the progression of this neurodegenerative disease at its early stage. On the other hand, amnestic mild cognitive impairment

Read More »
New Technology

Ultrasound Neuromodulation as a New Brain Therapy

Ultrasound has been “rediscovered” as a method for brain therapy within the last decade. Progressive technologies allow for the focusing of ultrasound through the human skull and enable non-invasive stimulation or ablation of brain

Read More »
Specialties
Time
Drug